{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:06:26Z","timestamp":1789574786812,"version":"build-2803163510"},"reference-count":63,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>As the obesity pandemic worsens, cases of pediatric nonalcoholic fatty liver disease (NAFLD) and complications of this disease, such as progressive liver failure, in young adults will continue to rise. Lifestyle changes in the form of dietary modifications and exercise are currently first-line treatments. Large pediatric-specific randomized controlled trials to support specific interventions are currently lacking. A variety of dietary modifications in children with NAFLD have been suggested and studied with mixed results, including low-sugar and high-protein diets, the Mediterranean diet, and the Dietary Approach to Stop Hypertension (DASH). The roles of dietary supplements such as Vitamin E, polyunsaturated fatty acids (PUFAs), ginger, and probiotics have also been investigated. A further understanding of specific dietary interventions and supplements is needed to provide both generalizable and sustainable dietary recommendations to reverse the progression of NAFLD in the pediatric population.<\/jats:p>","DOI":"10.3390\/nu15153350","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T07:35:24Z","timestamp":1690529724000},"page":"3350","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["You Are What You Eat: A Review on Dietary Interventions for Treating Pediatric Nonalcoholic Fatty Liver Disease"],"prefix":"10.3390","volume":"15","author":[{"given":"Piper","family":"Sandel","sequence":"first","affiliation":[{"name":"Section of Academic General Pediatrics, Department of Pediatrics, University of California San Diego, San Diego, CA 92123, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Ma","sequence":"additional","affiliation":[{"name":"Section of Academic General Pediatrics, Department of Pediatrics, University of California San Diego, San Diego, CA 92123, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3453-3572","authenticated-orcid":false,"given":"Helen","family":"Wang","sequence":"additional","affiliation":[{"name":"Section of Academic General Pediatrics, Department of Pediatrics, University of California San Diego, San Diego, CA 92123, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Pasman","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Department of Pediatrics, Naval Medical Center San Diego, San Diego, CA 92134, USA"},{"name":"Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1542\/peds.2006-1212","article-title":"Prevalence of Fatty Liver in Children and Adolescents","volume":"118","author":"Schwimmer","year":"2006","journal-title":"Pediatrics"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e20200771","DOI":"10.1542\/peds.2020-0771","article-title":"Incidence of Nonalcoholic Fatty Liver Disease in Children: 2009\u20132018","volume":"146","author":"Sahota","year":"2020","journal-title":"Pediatrics"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Anderson, E.L., Howe, L.D., Jones, H.E., Higgins, J.P.T., Lawlor, D.A., and Fraser, A. (2015). The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140908"},{"key":"ref_4","first-page":"407","article-title":"Overview of Updated Practice Guidelines for Pediatric Nonalcoholic Fatty Liver Disease","volume":"14","author":"Shah","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/oby.20174","article-title":"Nonalcoholic Fatty Liver Disease in Severely Obese Adolescent and Adult Patients","volume":"21","author":"Holterman","year":"2013","journal-title":"Obesity"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.3748\/wjg.v20.i18.5320","article-title":"Liver Transplantation for Nonalcoholic Fatty Liver Disease: New Challenges and New Opportunities","volume":"20","author":"Shaker","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"Outcomes of Liver Transplantation for Non-Alcoholic Steatohepatitis: A European Liver Transplant Registry Study","volume":"71","author":"Haldar","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/j.gastro.2017.05.043","article-title":"Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity","volume":"153","author":"Schwarz","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mandala, A., Janssen, R.C., Palle, S., Short, K.R., and Friedman, J.E. (2020). Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms. Nutrients, 12.","DOI":"10.3390\/nu12103166"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The Multiple-Hit Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_12","unstructured":"Jenco, M. (2023, June 24). AAP Endorses New Guidelines on Non-Alcoholic Fatty Liver Disease. Available online: https:\/\/publications.aap.org\/aapnews\/news\/6626\/AAP-endorses-new-guidelines-on-non-alcoholic-fatty."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.27395","article-title":"The Role of Liver Fat and Insulin Resistance as Determinants of Plasma Aminotransferase Elevation in Nonalcoholic Fatty Liver Disease","volume":"61","author":"Maximos","year":"2015","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s42255-020-0261-2","article-title":"Fructose Stimulated de Novo Lipogenesis Is Promoted by Inflammation","volume":"2","author":"Todoric","year":"2020","journal-title":"Nat. Metab."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jhep.2016.12.025","article-title":"Serum Uric Acid Concentrations and Fructose Consumption Are Independently Associated with NASH in Children and Adolescents","volume":"66","author":"Mosca","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/ijpo.12264","article-title":"Sugar Intake by Type (Added vs. Naturally Occurring) and Physical Form (Liquid vs. Solid) and Its Varying Association with Children\u2019s Body Weight, NHANES 2009-2014","volume":"13","author":"Welsh","year":"2018","journal-title":"Pediatr. Obes."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/0148607113501201","article-title":"The Effect of a Low Fructose and Low Glycemic Index\/Load (FRAGILE) Dietary Intervention on Indices of Liver Function, Cardiometabolic Risk Factors, and Body Composition in Children and Adolescents with Nonalcoholic Fatty Liver Disease (NAFLD)","volume":"39","author":"Mager","year":"2015","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jama.2018.20579","article-title":"Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial","volume":"321","author":"Schwimmer","year":"2019","journal-title":"JAMA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e150996","DOI":"10.1172\/JCI150996","article-title":"Dietary Sugar Restriction Reduces Hepatic de Novo Lipogenesis in Adolescent Boys with Fatty Liver Disease","volume":"131","author":"Cohen","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e12630","DOI":"10.1111\/ijpo.12630","article-title":"Effects of a Carbohydrate-Restricted Diet on Hepatic Lipid Content in Adolescents with Non-Alcoholic Fatty Liver Disease: A Pilot, Randomized Trial","volume":"15","author":"Goss","year":"2020","journal-title":"Pediatr. Obes."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.3390\/nu6083187","article-title":"Dietary Fructose Reduction Improves Markers of Cardiovascular Disease Risk in Hispanic-American Adolescents with NAFLD","volume":"6","author":"Jin","year":"2014","journal-title":"Nutrients"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure. DASH Collaborative Research Group","volume":"336","author":"Appel","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.HYP.0000053450.19998.11","article-title":"DASH Diet Lowers Blood Pressure and Lipid-Induced Oxidative Stress in Obesity","volume":"41","author":"Lopes","year":"2003","journal-title":"Hypertension"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/obr.12391","article-title":"The Effect of Dietary Approaches to Stop Hypertension (DASH) Diet on Weight and Body Composition in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials","volume":"17","author":"Soltani","year":"2016","journal-title":"Obes. Rev. Off. J. Int. Assoc. Study Obes."},{"key":"ref_25","first-page":"563","article-title":"The Effects of DASH Diet on Weight Loss and Metabolic Status in Adults with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial","volume":"36","author":"Telkabadi","year":"2016","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000358341","article-title":"The Dietary Approaches to Stop Hypertension (DASH) Diet Affects Inflammation in Childhood Metabolic Syndrome: A Randomized Cross-over Clinical Trial","volume":"64","author":"Saneei","year":"2014","journal-title":"Ann. Nutr. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Costello, E., Goodrich, J., Patterson, W.B., Rock, S., Li, Y., Baumert, B., Gilliland, F., Goran, M.I., Chen, Z., and Alderete, T.L. (2022). Diet Quality Is Associated with Glucose Regulation in a Cohort of Young Adults. Nutrients, 14.","DOI":"10.3390\/nu14183734"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clnesp.2018.09.003","article-title":"de A.G. Effects of the Dietary Approach to Stop Hypertension (DASH) Diet on Blood Pressure, Overweight and Obesity in Adolescents: A Systematic Review","volume":"28","author":"Poltronieri","year":"2018","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3748\/wjg.v24.i19.2083","article-title":"Mediterranean Diet and Nonalcoholic Fatty Liver Disease","volume":"24","author":"Anania","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Perumpail, B.J., Cholankeril, R., Yoo, E.R., Kim, D., and Ahmed, A. (2017). An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease. Diseases, 5.","DOI":"10.3390\/diseases5040023"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/09637486.2016.1214239","article-title":"Mediterranean Diet and Nonalcoholic Fatty Liver Disease: Molecular Mechanisms of Protection","volume":"68","author":"Godos","year":"2017","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_32","first-page":"S102","article-title":"The Role of Nutrition in Non-Alcoholic Fatty Liver Disease: Pathophysiology and Management","volume":"40","year":"2020","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIRCULATIONAHA.117.030501","article-title":"Effect of Distinct Lifestyle Interventions on Mobilization of Fat Storage Pools: CENTRAL Magnetic Resonance Imaging Randomized Controlled Trial","volume":"137","author":"Gepner","year":"2018","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.clnu.2022.06.037","article-title":"The Effectiveness and Acceptability of Mediterranean Diet and Calorie Restriction in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis","volume":"41","author":"Haigh","year":"2022","journal-title":"Clin. Nutr. Edinb. Scotl."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/09637486.2021.1979478","article-title":"The Effect of a Mediterranean Diet vs. a Low-Fat Diet on Non-Alcoholic Fatty Liver Disease in Children: A Randomized Trial","volume":"73","author":"Akbulut","year":"2022","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3945\/jn.114.205203","article-title":"Higher-Protein Diets Are Associated with Higher HDL Cholesterol and Lower BMI and Waist Circumference in US Adults","volume":"145","author":"Pasiakos","year":"2015","journal-title":"J. Nutr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7150\/ijbs.30121","article-title":"Role of Nutrition in the Pathogenesis and Prevention of Non-Alcoholic Fatty Liver Disease: Recent Updates","volume":"15","author":"Ullah","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.nut.2010.09.004","article-title":"Soy Protein Retards the Progression of Non-Alcoholic Steatohepatitis via Improvement of Insulin Resistance and Steatosis","volume":"27","author":"Yang","year":"2011","journal-title":"Nutrition"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jhep.2012.07.003","article-title":"Phenotyping the Effect of Diet on Non-Alcoholic Fatty Liver Disease","volume":"57","author":"Afman","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MCO.0000000000000706","article-title":"Protein and Amino Acids in Nonalcoholic Fatty Liver Disease","volume":"24","author":"Biancalana","year":"2021","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_41","first-page":"94","article-title":"Hypocaloric High-Protein Diet Improves Clinical and Biochemical Markers in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)","volume":"29","author":"Faintuch","year":"2014","journal-title":"Nutr. Hosp."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/j.gastro.2016.10.007","article-title":"Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals with Type 2 Diabetes","volume":"152","author":"Markova","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0022-3476(99)70409-9","article-title":"Comparison of Serum Concentrations of Alpha-Tocopherol and Beta-Carotene in a Cross-Sectional Sample of Obese and Nonobese Children (NHANES III). National Health and Nutrition Examination Survey","volume":"134","author":"Strauss","year":"1999","journal-title":"J. Pediatr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3748\/wjg.14.1598","article-title":"Effect of Lifestyle Intervention on Non-Alcoholic Fatty Liver Disease in Chinese Obese Children","volume":"14","author":"Wang","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/hep.22336","article-title":"Lifestyle Intervention and Antioxidant Therapy in Children with Nonalcoholic Fatty Liver Disease: A Randomized, Controlled Trial","volume":"48","author":"Nobili","year":"2008","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents: The TONIC Randomized Controlled Trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/fsn3.3218","article-title":"Combination of the Effect of Ginger and Anti-Inflammatory Diet on Children with Obesity with Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial","volume":"11","author":"Kamari","year":"2023","journal-title":"Food Sci. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/hep.27695","article-title":"Altered Hepatic Gene Expression in Nonalcoholic Fatty Liver Disease Is Associated with Lower Hepatic N-3 and n-6 Polyunsaturated Fatty Acids","volume":"61","author":"Arendt","year":"2015","journal-title":"Hepatology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pharmthera.2017.07.007","article-title":"Omega-3 Polyunsaturated Fatty Acids as a Treatment Strategy for Nonalcoholic Fatty Liver Disease","volume":"181","author":"Jump","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-nutr-071812-161139","article-title":"Fatty Acid-Regulated Transcription Factors in the Liver","volume":"33","author":"Jump","year":"2013","journal-title":"Annu. Rev. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/adc.2010.192401","article-title":"Docosahexaenoic Acid Supplementation Decreases Liver Fat Content in Children with Non-Alcoholic Fatty Liver Disease: Double-Blind Randomised Controlled Clinical Trial","volume":"96","author":"Nobili","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.numecd.2012.10.010","article-title":"Docosahexaenoic Acid for the Treatment of Fatty Liver: Randomised Controlled Trial in Children","volume":"23","author":"Nobili","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis. NMCD"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.numecd.2015.04.003","article-title":"A Double-Blind, Placebo-Controlled Randomized Trial to Evaluate the Efficacy of Docosahexaenoic Acid Supplementation on Hepatic Fat and Associated Cardiovascular Risk Factors in Overweight Children with Nonalcoholic Fatty Liver Disease","volume":"25","author":"Pacifico","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis. NMCD"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpeds.2015.01.056","article-title":"Omega-3 Fatty Acids Therapy in Children with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial","volume":"166","author":"Janczyk","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4274\/jcrpe.1749","article-title":"Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease","volume":"7","author":"Boyraz","year":"2015","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jnutbio.2018.03.025","article-title":"Non-Alcoholic Fatty Liver Disease Severity and Metabolic Complications in Obese Children: Impact of Omega-3 Fatty Acids","volume":"58","author":"Spahis","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","article-title":"Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?","volume":"158","author":"Warmbrunn","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MPG.0000000000001422","article-title":"Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents","volume":"64","author":"Famouri","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/MPG.0b013e31821f9b85","article-title":"Effects of Lactobacillus Rhamnosus Strain GG in Pediatric Obesity-Related Liver Disease","volume":"52","author":"Vajro","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/apt.12758","article-title":"Randomised Clinical Trial: The Beneficial Effects of VSL#3 in Obese Children with Non-Alcoholic Steatohepatitis","volume":"39","author":"Alisi","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1136\/gut.2008.171280","article-title":"The Natural History of Non-Alcoholic Fatty Liver Disease in Children: A Follow-up Study for up to 20 Years","volume":"58","author":"Feldstein","year":"2009","journal-title":"Gut"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11894-021-00827-0","article-title":"Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician\u2019s Guide","volume":"23","author":"Aboubakr","year":"2021","journal-title":"Curr. Gastroenterol. Rep."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/15\/3350\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:21:14Z","timestamp":1760127674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/15\/15\/3350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":63,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["nu15153350"],"URL":"https:\/\/doi.org\/10.3390\/nu15153350","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]}}}